Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
PTW On Other Exchanges
All times are local (Market data is delayed by at least 15 minutes).

petroworth resources inc (PTW) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

petroworth resources inc (PTW) Related Businessweek News

No Related Businessweek News Found

petroworth resources inc (PTW) Details

M Pharmaceutical Inc. focuses on pharmaceuticals and biomedical devices business. It intends to develop eMosquito for persons with diabetes to take blood samples for glucose level checks. The company was formerly known as First Sahara Energy Inc. and changed its name to M Pharmaceutical Inc. in November 2014. M Pharmaceutical Inc. was founded in 2003 and is based in Toronto, Canada.

Founded in 2003

petroworth resources inc (PTW) Top Compensated Officers

Chief Financial Officer
Total Annual Compensation: C$17.8K
Compensation as of Fiscal Year 2013.

petroworth resources inc (PTW) Key Developments

M Pharmaceutical Inc. Appoints Christopher Andrews to Board of Directors

Dr. Christopher Andrews, M.D., MSc, FRCPC, is joining the Board of Directors of M Pharmaceutical Inc. Dr. Andrews, who specializes in stomach disorders and physiology, is the latest leadership asset to join the Company, which is committed to developing and commercializing innovative biomedical technologies that improve the health and quality of life for people affected by obesity or diabetes. Dr. Andrews is a Clinical Associate Professor at the University of Calgary.

M Pharmaceutical Inc. Appoints Martin Mintchev as President & Chief Executive Officer

M Pharmaceutical Inc. announced that, Dr. Martin Mintchev has been appointed the President & Chief Executive Officer of the Company.

M Pharmaceutical Inc. Announces the Appointment of Dr. Martin Mintchev as President & Chief Executive Officer

M Pharmaceutical Inc. announced that Dr. Martin Mintchev has accepted the position of President & Chief Executive Officer. Dr. Mintchev is the primary developer of the innovative medical technologies held by M Pharmaceutical. A veteran academic in the field, Dr. Mintchev will continue his role as a Professor in the Schulich School of Engineering at the University of Calgary, but will be able to devote the leadership required in order to move forward the development of the Company's medical devices. The Board of Directors of the company wishes to thank David Lane for his work and service to the company as its former president and director.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PTW:CN C$0.00 CAD 0.00

PTW Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PTW.
View Industry Companies

Industry Analysis


Industry Average

Valuation PTW Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PETROWORTH RESOURCES INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at